Cargando…
Postoperative Prognostic Predictors of Bile Duct Cancers: Clinical Analysis and Immunoassays of Tissue Microarrays
BACKGROUND/AIMS: Cholangiocarcinoma frequently recurs even after curative resection. Expression levels of proteins such as epidermal growth factor receptor (EGFR), Snail, epithelial cadherin (E-cadherin), and interleukin-6 (IL-6) examined by immunohistochemistry have been studied as potential progno...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Editorial Office of Gut and Liver
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9840923/ https://www.ncbi.nlm.nih.gov/pubmed/36317517 http://dx.doi.org/10.5009/gnl220044 |
_version_ | 1784869717690810368 |
---|---|
author | Chung, Hwe Hoon Seo, Seung Hee Kim, Hyemin Kim, Yuil Kim, Dong Wuk Lee, Kwang Hyuck Lee, Kyu Taek Heo, Jin Seok Han, In Woong Park, Seon Mee Jang, Kee-Taek Lee, Jong Kyun Park, Joo Kyung |
author_facet | Chung, Hwe Hoon Seo, Seung Hee Kim, Hyemin Kim, Yuil Kim, Dong Wuk Lee, Kwang Hyuck Lee, Kyu Taek Heo, Jin Seok Han, In Woong Park, Seon Mee Jang, Kee-Taek Lee, Jong Kyun Park, Joo Kyung |
author_sort | Chung, Hwe Hoon |
collection | PubMed |
description | BACKGROUND/AIMS: Cholangiocarcinoma frequently recurs even after curative resection. Expression levels of proteins such as epidermal growth factor receptor (EGFR), Snail, epithelial cadherin (E-cadherin), and interleukin-6 (IL-6) examined by immunohistochemistry have been studied as potential prognostic factors for cholangiocarcinoma. The aim of this study was to investigate significant factors affecting the prognosis of resectable cholangiocarcinoma. METHODS: Ninety-one patients who underwent surgical resection at Samsung Medical Center for cholangiocarcinoma from 1995 to 2013 were included in this study. Expression levels of E-cadherin, Snail, IL-6, membranous EGFR, and cytoplasmic EGFR were analyzed by immunohistochemistry using tissue microarray blocks made from surgical specimens. RESULTS: Patients with high levels of membranous EGFR in tissue microarrays had significantly shorter overall survival (OS) and disease-free survival (DFS) high membranous EGFR (score 0–2) 38.0 months versus low membranous EGFR (score 3) 14.4 months (p=0.008) and high membranous EGFR (score 0–2) 23.2 months versus low membranous EGFR (score 3) 6.1 months (p=0.004), respectively. On the other hand, E-cadherin, Snail, cytoplasmic EGFR, and IL-6 did not show significant association with OS or DFS. Patients with distant metastasis had significantly higher IL-6 levels than those with locoregional recurrence (p=0.01). CONCLUSIONS: This study showed that overexpression of membranous EGFR was significantly associated with shorter OS and DFS in surgically resected bile duct cancer patients. In addition, higher IL-6 expression was a predictive marker for recurrence in cholangiocarcinoma patients with distant organ metastasis after surgical resection. |
format | Online Article Text |
id | pubmed-9840923 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Editorial Office of Gut and Liver |
record_format | MEDLINE/PubMed |
spelling | pubmed-98409232023-01-30 Postoperative Prognostic Predictors of Bile Duct Cancers: Clinical Analysis and Immunoassays of Tissue Microarrays Chung, Hwe Hoon Seo, Seung Hee Kim, Hyemin Kim, Yuil Kim, Dong Wuk Lee, Kwang Hyuck Lee, Kyu Taek Heo, Jin Seok Han, In Woong Park, Seon Mee Jang, Kee-Taek Lee, Jong Kyun Park, Joo Kyung Gut Liver Original Article BACKGROUND/AIMS: Cholangiocarcinoma frequently recurs even after curative resection. Expression levels of proteins such as epidermal growth factor receptor (EGFR), Snail, epithelial cadherin (E-cadherin), and interleukin-6 (IL-6) examined by immunohistochemistry have been studied as potential prognostic factors for cholangiocarcinoma. The aim of this study was to investigate significant factors affecting the prognosis of resectable cholangiocarcinoma. METHODS: Ninety-one patients who underwent surgical resection at Samsung Medical Center for cholangiocarcinoma from 1995 to 2013 were included in this study. Expression levels of E-cadherin, Snail, IL-6, membranous EGFR, and cytoplasmic EGFR were analyzed by immunohistochemistry using tissue microarray blocks made from surgical specimens. RESULTS: Patients with high levels of membranous EGFR in tissue microarrays had significantly shorter overall survival (OS) and disease-free survival (DFS) high membranous EGFR (score 0–2) 38.0 months versus low membranous EGFR (score 3) 14.4 months (p=0.008) and high membranous EGFR (score 0–2) 23.2 months versus low membranous EGFR (score 3) 6.1 months (p=0.004), respectively. On the other hand, E-cadherin, Snail, cytoplasmic EGFR, and IL-6 did not show significant association with OS or DFS. Patients with distant metastasis had significantly higher IL-6 levels than those with locoregional recurrence (p=0.01). CONCLUSIONS: This study showed that overexpression of membranous EGFR was significantly associated with shorter OS and DFS in surgically resected bile duct cancer patients. In addition, higher IL-6 expression was a predictive marker for recurrence in cholangiocarcinoma patients with distant organ metastasis after surgical resection. Editorial Office of Gut and Liver 2023-01-15 2022-11-01 /pmc/articles/PMC9840923/ /pubmed/36317517 http://dx.doi.org/10.5009/gnl220044 Text en Copyright © Gut and Liver. https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Chung, Hwe Hoon Seo, Seung Hee Kim, Hyemin Kim, Yuil Kim, Dong Wuk Lee, Kwang Hyuck Lee, Kyu Taek Heo, Jin Seok Han, In Woong Park, Seon Mee Jang, Kee-Taek Lee, Jong Kyun Park, Joo Kyung Postoperative Prognostic Predictors of Bile Duct Cancers: Clinical Analysis and Immunoassays of Tissue Microarrays |
title | Postoperative Prognostic Predictors of Bile Duct Cancers: Clinical Analysis and Immunoassays of Tissue Microarrays |
title_full | Postoperative Prognostic Predictors of Bile Duct Cancers: Clinical Analysis and Immunoassays of Tissue Microarrays |
title_fullStr | Postoperative Prognostic Predictors of Bile Duct Cancers: Clinical Analysis and Immunoassays of Tissue Microarrays |
title_full_unstemmed | Postoperative Prognostic Predictors of Bile Duct Cancers: Clinical Analysis and Immunoassays of Tissue Microarrays |
title_short | Postoperative Prognostic Predictors of Bile Duct Cancers: Clinical Analysis and Immunoassays of Tissue Microarrays |
title_sort | postoperative prognostic predictors of bile duct cancers: clinical analysis and immunoassays of tissue microarrays |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9840923/ https://www.ncbi.nlm.nih.gov/pubmed/36317517 http://dx.doi.org/10.5009/gnl220044 |
work_keys_str_mv | AT chunghwehoon postoperativeprognosticpredictorsofbileductcancersclinicalanalysisandimmunoassaysoftissuemicroarrays AT seoseunghee postoperativeprognosticpredictorsofbileductcancersclinicalanalysisandimmunoassaysoftissuemicroarrays AT kimhyemin postoperativeprognosticpredictorsofbileductcancersclinicalanalysisandimmunoassaysoftissuemicroarrays AT kimyuil postoperativeprognosticpredictorsofbileductcancersclinicalanalysisandimmunoassaysoftissuemicroarrays AT kimdongwuk postoperativeprognosticpredictorsofbileductcancersclinicalanalysisandimmunoassaysoftissuemicroarrays AT leekwanghyuck postoperativeprognosticpredictorsofbileductcancersclinicalanalysisandimmunoassaysoftissuemicroarrays AT leekyutaek postoperativeprognosticpredictorsofbileductcancersclinicalanalysisandimmunoassaysoftissuemicroarrays AT heojinseok postoperativeprognosticpredictorsofbileductcancersclinicalanalysisandimmunoassaysoftissuemicroarrays AT haninwoong postoperativeprognosticpredictorsofbileductcancersclinicalanalysisandimmunoassaysoftissuemicroarrays AT parkseonmee postoperativeprognosticpredictorsofbileductcancersclinicalanalysisandimmunoassaysoftissuemicroarrays AT jangkeetaek postoperativeprognosticpredictorsofbileductcancersclinicalanalysisandimmunoassaysoftissuemicroarrays AT leejongkyun postoperativeprognosticpredictorsofbileductcancersclinicalanalysisandimmunoassaysoftissuemicroarrays AT parkjookyung postoperativeprognosticpredictorsofbileductcancersclinicalanalysisandimmunoassaysoftissuemicroarrays |